Impairment of Gastric Emptying During Acute Phase of Myocardial Infarction. Impact on Oral Antiplatelet Treatment Efficacy. The GASTRIM Study.

Trial Profile

Impairment of Gastric Emptying During Acute Phase of Myocardial Infarction. Impact on Oral Antiplatelet Treatment Efficacy. The GASTRIM Study.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 01 Feb 2017

At a glance

  • Drugs Prasugrel (Primary) ; Ticagrelor (Primary) ; Paracetamol
  • Indications Coronary artery disease; Myocardial infarction
  • Focus Pharmacokinetics
  • Acronyms The GASTRIM study
  • Most Recent Events

    • 24 Jan 2017 Planned End Date changed from 1 Oct 2015 to 8 Jun 2017.
    • 24 Jan 2017 Planned primary completion date changed from 1 Oct 2015 to 8 Jun 2017.
    • 24 Jan 2017 Status changed from not yet recruiting to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top